CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $60,444 | -12.4% | 10,350 | 0.0% | 0.01% | -25.0% |
Q3 2022 | $69,000 | +56.8% | 10,350 | -0.5% | 0.01% | +60.0% |
Q2 2022 | $44,000 | +25.7% | 10,400 | 0.0% | 0.01% | +66.7% |
Q1 2022 | $35,000 | +6.1% | 10,400 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $33,000 | -44.1% | 10,400 | -25.2% | 0.00% | -50.0% |
Q3 2021 | $59,000 | 0.0% | 13,900 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $59,000 | +3.5% | 13,900 | +21.9% | 0.01% | 0.0% |
Q1 2021 | $57,000 | +46.2% | 11,400 | +185.0% | 0.01% | +20.0% |
Q3 2020 | $39,000 | 0.0% | 4,000 | 0.0% | 0.01% | -16.7% |
Q2 2020 | $39,000 | 0.0% | 4,000 | -9.1% | 0.01% | -25.0% |
Q1 2020 | $39,000 | -15.2% | 4,400 | -12.0% | 0.01% | 0.0% |
Q4 2019 | $46,000 | +58.6% | 5,000 | 0.0% | 0.01% | +33.3% |
Q3 2019 | $29,000 | +31.8% | 5,000 | +163.2% | 0.01% | +20.0% |
Q2 2019 | $22,000 | 0.0% | 1,900 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $22,000 | -4.3% | 1,900 | 0.0% | 0.01% | -16.7% |
Q4 2018 | $23,000 | -14.8% | 1,900 | 0.0% | 0.01% | +20.0% |
Q3 2018 | $27,000 | -12.9% | 1,900 | 0.0% | 0.01% | -16.7% |
Q2 2018 | $31,000 | – | 1,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |